Select Medical (SEM) EBITDA (2010 - 2026)
Select Medical (SEM) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Select Medical (SEM) EBITDA is $465M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Select Medical (SEM) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +3.98% |
| 3 Years TTM | +5.20% |
| 5 Years TTM | -11.25% |
| 10 Years TTM | +1.40% |
| All Time TTM | +3.94% |
Annual EBITDA change of Select Medical (SEM)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $136M | -71.44% |
| 2025 | $476M | +0.90% |
| 2024 | $472M | -0.79% |
| 2023 | $476M | +35.77% |
| 2022 | $351M | -61.74% |
| 2021 | $916M | +18.50% |
| 2020 | $773M | +12.98% |
| 2019 | $684M | +10.59% |
| 2018 | $619M | +19.97% |
| 2017 | $516M | +15.89% |
| 2016 | $445M | +17.22% |
| 2015 | $380M | +7.64% |
| 2014 | $353M | -3.55% |
| 2013 | $366M | -8.58% |
| 2012 | $400M | +4.69% |
| 2011 | $382M | +25.39% |
| 2010 | $305M | -0.65% |
| 2009 | $307M | N/A |
Comparison Select Medical (SEM) five years EBITDA CAGR with competitors
Select Medical (SEM) five years EBITDA CAGR is -11.25%.